Sunday, September 7, 2025

Latest

Pure Extracts Begins Build-Out Of Facility For Mushroom Extraction

Pure Extracts (CSE: PULL) has begun the build-out and construction of the fourth unit in its extraction facility, which will be used for the extraction of mushrooms as well as to conduct research and development on psilocybin. The announcement, made this morning, is part of Pure’s preparatory work on the anticipation of being granted a Dealer’s License by Health Canada.

The buildout is in connection with the prior announcement made by the company that it is working towards submitting an application to Health Canada for a Dealer’s License. If granted, the license will enable the company to have legal access to controlled substances. Further, it enables the company to produce, distribute and sell psilocybin among other substances.

More specifically, the license allows for a number of activities, including procurement of controlled substances, the research and manufacture of such substances, as well as the sale of substances via networks such as pharmacies as well as on a business to business basis.

“As a plant-based extractor bringing functional mushroom products to market in Q1 2021, we are very excited to be building-out our facility for our move into the controlled substances world of psychedelics. It’s great to have space adjacent to our cutting-edge facility which is built to Health Canada standards and to know that this space will also have the same high standards of construction that Pure Extracts prides itself on.”

Ben Nikolaevsky, CEO of Pure Extracts

Pure Extracts last traded at $0.73 on the CSE.


FULL DISCLOSURE: Pure Extracts is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pure Extracts on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Pure Extracts Announces Study Focused on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts (CSE: PULL) this morning announced that it has begun a study focused on...

Wednesday, December 30, 2020, 07:07:46 AM

Pure Extracts Announces Step Into Functional Mushroom Market

Pure Extracts (CSE: PULL) this morning released to the market its roadmap for the processing...

Thursday, November 26, 2020, 08:42:08 AM

Pure Extracts: The Second Wave of Psychedelic Operators

Some years ago when the first wave of cannabis firms went public, operators were focused...

Saturday, June 13, 2020, 08:30:00 AM

Pure Extracts Applies For Dealers License With Health Canada

Pure Extracts (CSE: PULL) continues to focus on the development of its mushroom-related operations in...

Thursday, March 4, 2021, 07:13:41 AM

Pure Extracts Sees First Commercial Sale Of CBD Oil

Pure Extracts (CSE: PULL) has completed its first commercial sale of CBD oil, and thereby...

Wednesday, February 10, 2021, 07:11:33 AM